Issue link: https://beckershealthcare.uberflip.com/i/576097
RESPIRATORY COMPROMISE RESPIRATORY INSUFFICIENCY, ARREST AND FAILURE. = HOW MANY RAPID RESPONSE NALOXONE ADMINISTRATIONS ICU BOUNCE BACKS IN THE LAST MONTH? COMMON COSTLY DEADLY CONTINUOUS MONITORING OF RESPIRATORY STATUS AT THE BEDSIDE AND CENTRAL MONITORING STATION EARLIER INTERVENTION OF RESPIRATORY COMPROMISE REDUCTION IN COSTS ASSOCIATED WITH INTERVENTION COULD YOU REDUCE RAPID RESPONSE CALLS, BOUNCE BACKS OR READMISSIONS? SpO 2 RR etCO 2 Remote Monitoring CONTINUOUS MONITORING HAS BEEN SHOWN TO REDUCE RESCUE EVENTS ANDICU TRANSFERS 5 COVIDIEN OFFERS A FULL SUITE OF CONTINUOUS RESPIRATORY FUNCTION MONITORING SOLUTIONS. PATIENTS WITH RESPIRATORY COMPROMISE THAT ORIGINATED ON THE GENERAL CARE FLOOR, ARE MORE LIKELY TO DIE, COMPARED TO THE REST OF THE PATIENT POPULATION. 4 TIMES Patients with respiratory compromise that originated on the general care floor will be in the hospital 7days longer and in the ICU almost 3 days longer than patients without respiratory compromise 4 Inpatient stays related to respiratory compromise surpassed $7 Billion annually in the U.S. in 2007. Expected to surpass $37 Billion by 2019. 2 Patients with hospital contracted respiratory compromise will on average cost the hospital an additional than patients without respiratory compromise 4 $18,208+ $7 BILLION [ IN 2007 ] $ $ $ $ $ $ $ $$$ $$$ $$$ $37+ BILLION [ BY 2019 ] 2019 Nearly 30% of post- operative patients 1 and up to 7% of all Medicare patients 2 will suffer from respiratory compromise CASES OF RESPIRATORY COMPROMISE ARE EXPECTED TO INCREASE BY 31% BY 2019 2 50 40 30 20 10 0 2009 2019 +31% STANDARDS AND GUIDING BODIES recommend that patients should be continuously monitored for respiratory compromise. 6 To learn more about respiratory compromise visit covidien.com/rms/clinical-solutions/respiratory-compromise CONTINUOUS PATIENT MONITORING 97 110 14 SpO 2 PR RR 96 100 3SpO 2 3PR 98 80 6 3SpO 2 3PR 6RR 98 90 16 45 3SpO 2 3PR 3RR 3etCO 2 IS THE BEST WAY TO PREVENT AND INTERVENE EARLIER AND IMPROVE PATIENT SAFETY. ©2015 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. All other brands are trademarks of a Medtronic company. 09/2015 15-RE-0013a 1. Linde-Zwirble WL, Bloom JD, Mecca RS, Hansell DM. Postoperative pulmonary complications in adult elective surgery patients in the US: severity, outcomes and resources use. International Symposium on Intensive Care and Emergency Medicine (ISICEM) annual meeting. March 9-12, 2010; Brussels, Belgium. Crit Care Med. 2010;14(Suppl 1):P210. 2. Agarwal SJ, Erlson MG, Bloom JD. Projected incidence and cost of respiratory failure, insufficiency and arrest in Medicare population, 2019. Abstract presented at Academy Health Congress, June 2011. 3. Wier LM, Henke R, Friedman B. Diagnostic Groups with Rapidly Increasing Costs, by Payer, 2001-2007. Healthcare Cost and Utilization Project. Agency for Healthcare Research and Quality. Statistical Brief #91. June 2010. 4. Kelley SD, Agarwal S, Parikh N, Erlson M, Morris P. Respiratory insufficiency, arrest and failure among medical patients on the general care floor. Crit Care Med. 2012;40(12)-764. 5. Taenzer AH, Pyke JB, McGrath SP, Blike GT. Impact of pulse oximetry surveillance on rescue events and intensive care unit transfers: a before-and-after concurrence study. Anesthesiology. 2010;112(2):282-287. 6. American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology. 2002;96(4):1004-1017. 29 • Anesthesia Patient Safety Foundation • Medicare Inpatient Quality Reporting Program • Joint Commission Sentinel Event Alert #49 • American Society of Anesthesiologists • American Society for Pain Management Nursing